\-\ Texto\\:\\ \ \(0\)\
\-\ treatment\\ is\\ aimed\\ at\\ inhibiting\\ osteoclastic\\ activity\\ through\\ bisphosphonates\\.\\ \\ surgical\\ intervention\\ is\\ indicated\\ for\\ pathologic\\ fractures\\,\\ advanced\\ disabling\\ arthritis\\,\\ and\\ extreme\\ bowing\\ deformities\\ of\\ the\\ long\\ bones\\.\ \(0\)\
\-\ scout\\ image\\ reveals\\ bowing\\ of\\ the\\ left\\ femur\\,\\ with\\ an\\ osseous\\ abnormality\\ involving\\ the\\ distal\\ femur\\.\ \(0\)\
\-\ ap\\ and\\ lateral\\ radiograph\\ of\\ the\\ left\\ femur\\ reveals\\ a\\ blade\\ of\\ grass\\ appearance\\ of\\ osteoclastic\\ activity\\ in\\ the\\ mid\\-shaft\\ \\ cortex\\ with\\ sharp\\ borders\\,\\ advancing\\ along\\ the\\ shaft\\ of\\ the\\ femur\\.\\ \\ additionally\\,\\ bone\\ remodeling\\ with\\ thickening\\ of\\ the\\ cortex\\,\\ and\\ a\\ coarse\\ trabecular\\ pattern\\ in\\ the\\ medullary\\ portion\\ of\\ the\\ femur\\ is\\ noted\\.\\ \\ there\\ is\\ also\\ a\\ increase\\ in\\ bone\\ density\\,\\ with\\ diffuse\\ sclerotic\\ change\\,\\ enlargement\\ and\\ widening\\ of\\ the\\ epiphysis\\.\\ \\ bowing\\ is\\ evident\\.\\ \\ \ \(0\)\
\-\ frog\\ leg\\ radiograph\\ of\\ the\\ left\\ femur\\,\\ reveals\\ the\\ blade\\ of\\ grass\\ appearance\\ of\\ osteoclastic\\ activity\\ advancing\\ along\\ the\\ shaft\\ of\\ the\\ femur\\.\ \(0\)\
\-\ paget\\ disease\\ of\\ bone\ \(0\)\
\-\ lymphoma\\ \ \(115\)\
\-\ metastatic\\ cancer\ \(6\)\
\-\ familial\\ idiopathic\\ hyperphosphatasia\\ \\(juvenile\\ paget\\ disease\\)\\ where\\ the\\ articular\\ ends\\ of\\ the\\ bone\\ may\\ not\\ be\\ affected\\.\\ \\ \ \(0\)\
\-\ paget\\ disease\ \(0\)\
\-\ 60\\ yo\\ male\\ for\\ evaluation\\.\ \(1\)\
\-\ if\\ laboratory\\ markers\\ had\\ been\\ drawn\\,\\ one\\ would\\ expect\\ increased\\ levels\\ of\\ serum\\ alkaline\\ phosphatase\\ with\\ osteoblastic\\ activity\\,\\ and\\ high\\ urinary\\ levels\\ of\\ hydroxyproline\\ with\\ osteoclastic\\ activity\\.\ \(0\)\
\-\ complications\\ of\\ paget\\'s\\ disease\\ include\\ deformity\\ of\\ the\\ long\\ bones\\,\\ warmth\\ in\\ the\\ involved\\ extremity\\,\\ periosteal\\ tenderness\\,\\ bone\\ pain\\,\\ fractures\\,\\ secondary\\ osteoarthritis\\,\\ neural\\ compression\\,\\ and\\ sarcomatous\\ degeneration\\.\\ \\ \ \(0\)\
\-\ greenspan\\,\\ adam\\.\\ \\ orthopedic\\ radiology\\:\\ a\\ practical\\ approach\\.\\ \\ 2nd\\ edition\\.\\ \\ lippincott\\-raven\\ publishers\\ philadelphia\\,\\ pa\\,\\ 1997\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteoclastic\\:\\ 0\\.1160338749058079\ \(0\)\
\-\ femur\\:\\ 0\\.09228886111408098\ \(0\)\
\-\ paget\\:\\ 0\\.06768544257229683\ \(0\)\
\-\ bowing\\:\\ 0\\.05874979193347815\ \(0\)\
\-\ activity\\:\\ 0\\.05725083265681319\ \(0\)\
\-\ grass\\:\\ 0\\.0551207581092742\ \(0\)\
\-\ blade\\:\\ 0\\.05147200365380284\ \(0\)\
\-\ advancing\\:\\ 0\\.0501697068195603\ \(0\)\
\-\ bone\\:\\ 0\\.03791847645464053\ \(0\)\
\-\ shaft\\:\\ 0\\.036102273630520966\ \(0\)\
\-\ reveals\\:\\ 0\\.03582051161030382\ \(0\)\
\-\ inhibiting\\:\\ 0\\.0275603790546371\ \(0\)\
\-\ mid\\-shaft\\:\\ 0\\.0275603790546371\ \(0\)\
\-\ hydroxyproline\\:\\ 0\\.0275603790546371\ \(0\)\
\-\ lippincott\\-raven\\:\\ 0\\.0275603790546371\ \(0\)\
\-\ hyperphosphatasia\\:\\ 0\\.026532943081595026\ \(0\)\
\-\ greenspan\\:\\ 0\\.026532943081595026\ \(0\)\
\-\ publishers\\:\\ 0\\.026532943081595026\ \(0\)\
\-\ cortex\\:\\ 0\\.026117593748228352\ \(0\)\
\-\ bones\\:\\ 0\\.025757373365179123\ \(0\)\
\-\ levels\\:\\ 0\\.02519465280908545\ \(0\)\
\-\ frog\\:\\ 0\\.02508485340978015\ \(0\)\
\-\ adam\\:\\ 0\\.02508485340978015\ \(0\)\
\-\ aimed\\:\\ 0\\.024057417436738077\ \(0\)\
\-\ disabling\\:\\ 0\\.024057417436738077\ \(0\)\
\-\ sarcomatous\\:\\ 0\\.023636763737965277\ \(0\)\
\-\ fractures\\:\\ 0\\.023112775699859114\ \(0\)\
\-\ bisphosphonates\\:\\ 0\\.02292008268274331\ \(0\)\
\-\ practical\\:\\ 0\\.02232346095180343\ \(0\)\
\-\ ends\\:\\ 0\\.02158189179188113\ \(0\)\
\-\ long\\:\\ 0\\.021044439363090882\ \(0\)\
\-\ \\,\\:\\ 0\\.020303254913796552\ \(0\)\
\-\ markers\\:\\ 0\\.02028580074299053\ \(0\)\
\-\ expect\\:\\ 0\\.02028580074299053\ \(0\)\
\-\ along\\:\\ 0\\.020171813406132257\ \(0\)\
\-\ phosphatase\\:\\ 0\\.019988009282493918\ \(0\)\
\-\ disease\\:\\ 0\\.01995339344593863\ \(0\)\
\-\ extreme\\:\\ 0\\.01971314842129346\ \(0\)\
\-\ trabecular\\:\\ 0\\.01971314842129346\ \(0\)\
\-\ warmth\\:\\ 0\\.01971314842129346\ \(0\)\
\-\ osteoblastic\\:\\ 0\\.01958326397782605\ \(0\)\
\-\ alkaline\\:\\ 0\\.019457937835642942\ \(0\)\
\-\ radiograph\\:\\ 0\\.01944249038515259\ \(0\)\
\-\ scout\\:\\ 0\\.01933686086537265\ \(0\)\
\-\ remodeling\\:\\ 0\\.01933686086537265\ \(0\)\
\-\ drawn\\:\\ 0\\.018786322723132444\ \(0\)\
\-\ familial\\:\\ 0\\.018685712448251388\ \(0\)\
\-\ edition\\:\\ 0\\.018221236990222107\ \(0\)\
\-\ coarse\\:\\ 0\\.018051136815260483\ \(0\)\
\-\ appearance\\:\\ 0\\.01745647554810458\ \(0\)\
\-\ deformities\\:\\ 0\\.017237622776436513\ \(0\)\
\-\ philadelphia\\:\\ 0\\.0171077383329691\ \(0\)\
\-\ 1997\\:\\ 0\\.0171077383329691\ \(0\)\
\-\ borders\\:\\ 0\\.016982412190785997\ \(0\)\
\-\ epiphysis\\:\\ 0\\.016744228710433594\ \(0\)\
\-\ juvenile\\:\\ 0\\.016630840502167236\ \(0\)\
\-\ sharp\\:\\ 0\\.016520941721214544\ \(0\)\
\-\ articular\\:\\ 0\\.016362185426318707\ \(0\)\
\-\ approach\\:\\ 0\\.016017089584572024\ \(0\)\
\-\ advanced\\:\\ 0\\.015617382740986363\ \(0\)\
\-\ degeneration\\:\\ 0\\.01549350574817247\ \(0\)\
\-\ neural\\:\\ 0\\.015453150193694138\ \(0\)\
\-\ widening\\:\\ 0\\.015373781848034458\ \(0\)\
\-\ 2nd\\:\\ 0\\.015220148329878419\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.015145740876653983\ \(0\)\
\-\ serum\\:\\ 0\\.014729180506204838\ \(0\)\
\-\ medullary\\:\\ 0\\.014664243652336302\ \(0\)\
\-\ orthopedic\\:\\ 0\\.014568999912757152\ \(0\)\
\-\ periosteal\\:\\ 0\\.014476230318459793\ \(0\)\
\-\ urinary\\:\\ 0\\.014127521498588664\ \(0\)\
\-\ evident\\:\\ 0\\.01396515587688596\ \(0\)\
\-\ idiopathic\\:\\ 0\\.013912633921922761\ \(0\)\
\-\ sclerotic\\:\\ 0\\.013661020847099149\ \(0\)\
\-\ intervention\\:\\ 0\\.01358886832096515\ \(0\)\
\-\ pathologic\\:\\ 0\\.013358373602616682\ \(0\)\
\-\ 60\\:\\ 0\\.013314007459764693\ \(0\)\
\-\ additionally\\:\\ 0\\.01322689512717841\ \(0\)\
\-\ indicated\\:\\ 0\\.013205445041249084\ \(0\)\
\-\ affected\\:\\ 0\\.013205445041249084\ \(0\)\
\-\ deformity\\:\\ 0\\.013141857096129415\ \(0\)\
\-\ arthritis\\:\\ 0\\.013038330178724944\ \(0\)\
\-\ osseous\\:\\ 0\\.012957616493306224\ \(0\)\
\-\ radiology\\:\\ 0\\.01289825620317751\ \(0\)\
\-\ increase\\:\\ 0\\.012801463596828254\ \(0\)\
\-\ involved\\:\\ 0\\.012801463596828254\ \(0\)\
\-\ pa\\:\\ 0\\.012763469317524484\ \(0\)\
\-\ where\\:\\ 0\\.012455865197060418\ \(0\)\
\-\ enlargement\\:\\ 0\\.012109172880303911\ \(0\)\
\-\ complications\\:\\ 0\\.012093474267900204\ \(0\)\
\-\ leg\\:\\ 0\\.012000704673602845\ \(0\)\
\-\ change\\:\\ 0\\.011895433894556582\ \(0\)\
\-\ pattern\\:\\ 0\\.011665865496683137\ \(0\)\
\-\ compression\\:\\ 0\\.011424097593928309\ \(0\)\
\-\ abnormality\\:\\ 0\\.011259135513680543\ \(0\)\
\-\ laboratory\\:\\ 0\\.011246756199478807\ \(0\)\
\-\ ap\\:\\ 0\\.011161282034437277\ \(0\)\
\-\ extremity\\:\\ 0\\.011161282034437277\ \(0\)\
\-\ portion\\:\\ 0\\.01105430945485388\ \(0\)\
\-\ would\\:\\ 0\\.010860595994364605\ \(0\)\
\-\ involving\\:\\ 0\\.010708597371440334\ \(0\)\
\-\ thickening\\:\\ 0\\.010345087748904826\ \(0\)\
\-\ left\\:\\ 0\\.010243985027924087\ \(0\)\
\-\ density\\:\\ 0\\.010041540560214139\ \(0\)\
\-\ is\\:\\ 0\\.0100409067568701\ \(0\)\
\-\ cancer\\:\\ 0\\.010032733087017019\ \(0\)\
\-\ image\\:\\ 0\\.00953281845106286\ \(0\)\
\-\ the\\:\\ 0\\.00938120146203175\ \(0\)\
\-\ tenderness\\:\\ 0\\.009281829724577261\ \(0\)\
\-\ diffuse\\:\\ 0\\.009239312215626124\ \(0\)\
\-\ yo\\:\\ 0\\.009183398297509865\ \(0\)\
\-\ evaluation\\:\\ 0\\.008865138556524313\ \(0\)\
\-\ lymphoma\\:\\ 0\\.00872213797996245\ \(0\)\
\-\ through\\:\\ 0\\.008667703637217387\ \(0\)\
\-\ include\\:\\ 0\\.008561262457251024\ \(0\)\
\-\ secondary\\:\\ 0\\.008532249880388598\ \(0\)\
\-\ high\\:\\ 0\\.008351950218131484\ \(0\)\
\-\ been\\:\\ 0\\.008302838890942825\ \(0\)\
\-\ distal\\:\\ 0\\.008297423531950095\ \(0\)\
\-\ if\\:\\ 0\\.008281226549216555\ \(0\)\
\-\ one\\:\\ 0\\.008270469226109443\ \(0\)\
\-\ of\\:\\ 0\\.007905615054149214\ \(0\)\
\-\ metastatic\\:\\ 0\\.007682533584343179\ \(0\)\
\-\ increased\\:\\ 0\\.007466017077855913\ \(0\)\
\-\ noted\\:\\ 0\\.0072336471016164056\ \(0\)\
\-\ \\'s\\:\\ 0\\.006728737922739446\ \(0\)\
\-\ may\\:\\ 0\\.006694029888921871\ \(0\)\
\-\ lateral\\:\\ 0\\.0065952430200876795\ \(0\)\
\-\ had\\:\\ 0\\.006585177925859672\ \(0\)\
\-\ surgical\\:\\ 0\\.0064150777508980485\ \(0\)\
\-\ treatment\\:\\ 0\\.006177203427146025\ \(0\)\
\-\ in\\:\\ 0\\.00601996043057507\ \(0\)\
\-\ also\\:\\ 0\\.006016498548821969\ \(0\)\
\-\ a\\:\\ 0\\.005665711454551446\ \(0\)\
\-\ male\\:\\ 0\\.005518591206740976\ \(0\)\
\-\ for\\:\\ 0\\.005207915347447965\ \(0\)\
\-\ be\\:\\ 0\\.004706274011942604\ \(0\)\
\-\ there\\:\\ 0\\.004541841273089245\ \(0\)\
\-\ not\\:\\ 0\\.004410066684792626\ \(0\)\
\-\ an\\:\\ 0\\.004220231658159749\ \(0\)\
\-\ at\\:\\ 0\\.004134868402970118\ \(0\)\
\-\ \\:\\:\\ 0\\.004036695771395232\ \(0\)\
\-\ and\\:\\ 0\\.003857335837118967\ \(0\)\
\-\ pain\\:\\ 0\\.003727172026895481\ \(0\)\
\-\ \\(\\:\\ 0\\.0025798633080137876\ \(0\)\
\-\ \\)\\:\\ 0\\.0025483489004046607\ \(0\)\
\-\ with\\:\\ 0\\.0025072323447833515\ \(0\)\
\-\ \\.\\:\\ 0\\.0020285449198483587\ \(0\)\
